Evidence map›Paper›PMID 36171743›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.

Mengmeng Ji, Mei Wang, Wenjun Hu, Mohamed Ibrahim, Krista L. Lentine, Massini Merzkani, Haris Murad, Yazen Al-Hosni, Ronald Parsons, Jason Wellen and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Reassessing Simultaneous Pancreas-Kidney Vs. Kidney Transplant Alone: A Propensity-Weighted Analysis of Survival and Morbidity.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  5. Simultaneous Pancreas-Kidney Versus Kidney Transplant Alone: Real-World Outcomes in a Propensity-Matched Global Cohort.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mengmeng JiSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Mei WangSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Wenjun HuSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Mohamed IbrahimSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Krista L. LentineDivision of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States.
Massini MerzkaniSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Haris MuradSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Yazen Al-HosniSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Ronald ParsonsDivision of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, GA, United States.
Jason WellenSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Su-Hsin ChangSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Tarek AlhamadSchool of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Washington University in St. Louis · USAmerican Society of Transplantation · USDivision of Chemistry · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simultaneous pancreas-kidney transplantation (SPK) carries about a 7%-22% risk of technical failure, but the impact of early pancreas allograft loss on subsequent kidney graft and patient survival is not well-defined. We examined national transplant registry data for type 1 diabetic patients who received SPK between 2000 and 2021. Associations of transplant type (i.e., SPK, deceased-donor kidney transplant [DDKA], living-donor kidney transplant [LDKA]) with kidney graft failure and patient survival were estimated by multivariable inverse probability of treatment-weighted accelerated failure-time models. Compared to SPK recipients with a functioning pancreas graft 3 months posttransplant (SPK,P+), LDKA had 18% (Time Ratio [TR] 0.82, 95%CI: 0.70-0.95) less graft survival time and 18% (TR 0.82, 95%CI: 0.68-0.97) less patient survival time, DDKA had 23% (TR 0.77, 95%CI: 0.68-0.87) less graft survival time and 29% (TR 0.71, 95%CI: 0.62-0.81) less patient survival time, and SPK with early pancreas graft loss had 34% (TR 0.66, 95%CI: 0.56-0.78) less graft survival time and 34% (TR 0.66, 95%CI: 0.55-0.79) less patient survival time. In conclusion, SPK,P+ recipients have better kidney allograft and patient survival compared with LDKA and DDKA. Early pancreas graft failure results in inferior kidney and patient survival time compared to kidney transplant alone.

Indexed as

Diabetes Mellitus, Type 1Kidney TransplantationPancreas TransplantationAllograftsGraft SurvivalHumansPancreasPostoperative Complicationsallograft failureallograft survivalkidney transplantsimultaneous pancreas-kidney transplantationtype 1 diabetes mellitus

Identifiers

PMID36171743
PMCPMC9510367
OpenAlexW4296528572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.